Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ludwig Oxford-developed DNA methylation technology forms the basis of new startup company

Biotechnology company, Base Genomics, has launched based on Dr Chunxiao Song’s innovative TAPS technology.

Funding for COVID-19 research

Dr Francesco Boccellato is awarded money from Oxford’s COVID-19 Research Response Fund

Ludwig Oxford technology holds great promise for a multi-cancer blood test

Ongoing Oxford research aims to improve the sensitivity of cancer blood tests with the goal of earlier detection for a variety of cancers.

Professor Sir Peter Ratcliffe elected as an AACR Academy Fellow

Sir Peter joins the ranks of the American Association for Cancer Research’s finest scientists.

Prof Xin Lu honoured by the Royal Society

Ludwig Oxford Branch Director Xin Lu has been elected as a Fellow of the Royal Society for her contributions to cancer biology.

Investigating the genetic risk of adrenocortical carcinoma

Bond lab researchers study the genetic factors associated with the age-dependent incidence of adrenocortical carcinoma.

Adaptation of TAPS for long-read DNA methylation and hydroxymethylation sequencing

Chunxiao Song’s technology can now be used to measure DNA modifications on much longer sections of DNA.

Crowd-sourcing approach to improve endoscopic detection of cancer

Evaluating the algorithms developed to detect a range of imaging artefacts in endoscopy.

Peter Ratcliffe’s Life Scientific

Nobel Prize winner Professor Sir Peter Ratcliffe talks to Jim Al-Khalili on BBC Radio 4.

Anti-cancer HIF-2 inhibition affects the hypoxic ventilatory response

Researchers from Dr Tammie Bishop’s and Prof Sir Peter Ratcliffe’s laboratories show that an anti-cancer HIF inhibitor impairs the normal ventilatory response to low oxygen.

Curbing a cancer-causing pathogen

Ludo Buti and colleagues in Xin Lu’s research group find a path that could reduce colonisation of human stomach cells by the cancer-causing bacteria, Helicobacter pylori.

Global Youth Scientists Summit 2020

Yibin Liu represents Ludwig Oxford at the summit in Singapore.

Novel strategy for improving tuberculosis treatment

Pedro Moura Alves demonstrates that drugs used to treat TB interact with the Aryl hydrocarbon receptor to worsen treatment outcomes.

Christmas raffle for Sobell House

Public Engagement

Staff and students from the Old Road Campus Research Building, the NDM Research Building and the Kennedy Institute raised £750 for Sobell House in the Christmas raffle organised by Ludwig Oxford’s laboratory manager Dr Stan Ng. Thanks to all contributors and corporate donors Eppendorf UK, Thermofisher and Promega UK!

Support for the pathway tuning model of cancer

Researchers from David Mole’s and Peter Ratcliffe’s labs investigate a model for cancer evolution using renal clear cell carcinoma.

Spying on bacterial communication to fine-tune the body’s defences

Research published in the journal Science by Ludwig Oxford’s Pedro Moura Alves and Max Planck’s Stefan Kaufmann gives insights into the relationship between bacterial pathogens and the host organism during an infection.

Clinical trial for therapeutic cancer vaccine

Research from Benoit Van den Eynde’s laboratory forms the basis of a Phase I/IIa clinical trial.

NDM graduate prizes for Ludwig students

Two students from Ludwig Oxford have won Nuffield Department of Medicine Graduate Student prizes for 2019.

Ludwig Oxford retreat 2019

Two days of excellent science at the Institute’s annual retreat.

Nobel Prize 2019 awarded to Sir Peter Ratcliffe

Ludwig Oxford’s Professor Sir Peter Ratcliffe receives the Nobel Prize in physiology or medicine at an awards ceremony in Stockholm.

Load More